Screener
GNOM vs CGGR
Global X Genomics & Biotechnology ETF vs Capital Group Growth ETF
Key differences
- CGGR costs 0.11% less per year.
- CGGR is significantly larger than GNOM — larger funds tend to be more liquid and less likely to close.
- GNOM covers north america markets; CGGR covers global.
- GNOM follows a index tracking strategy; CGGR uses active selection.
- Over the last 3 years, CGGR has delivered higher annualized returns.
Side-by-side comparison
| GNOM | CGGR | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.39% |
| Fund size (AUM) | $51M | $22.2B |
| Since | 2019 | 2022 |
| Dividend yield | 1.38% | 0.10% |
| Asset class | equity | equity |
| Region | north america | global |
| Strategy | index tracking | active selection |
| CAGR 1Y | +53.6% | +22.6% |
| CAGR 3Y | -2.6% | +26.5% |
| CAGR 5Y | -10.5% | N/A |
| Sharpe 3Y | -0.06 | 1.14 |
| Volatility 1Y | 26.15% | 16.28% |
| Max drawdown | -75.00% | -28.90% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to GNOM and CGGR
Explore further